Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
SNES 
SenesTech Inc (SNES)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/13/2025: SNES (3-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $10
1 Year Target Price $10
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 51.59% | Avg. Invested days 58 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 11/13/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 14.67M USD | Price to earnings Ratio - | 1Y Target Price 10 |
Price to earnings Ratio - | 1Y Target Price 10 | ||
Volume (30-day avg) 1 | Beta 0.21 | 52 Weeks Range 1.30 - 6.24 | Updated Date 11/14/2025 |
52 Weeks Range 1.30 - 6.24 | Updated Date 11/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -4.3 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date 2025-11-11 | When After Market | Estimate -0.35 | Actual -0.28 |
Profitability
Profit Margin -253.54% | Operating Margin (TTM) -195.22% |
Management Effectiveness
Return on Assets (TTM) -38.54% | Return on Equity (TTM) -77.79% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 12138145 | Price to Sales(TTM) 6.38 |
Enterprise Value 12138145 | Price to Sales(TTM) 6.38 | ||
Enterprise Value to Revenue 5.8 | Enterprise Value to EBITDA 0.11 | Shares Outstanding 5185333 | Shares Floating 5002813 |
Shares Outstanding 5185333 | Shares Floating 5002813 | ||
Percent Insiders 4.22 | Percent Institutions 4.03 |
Upturn AI SWOT
SenesTech Inc
Company Overview
History and Background
SenesTech, Inc. was founded in 2004. It focuses on developing and commercializing technologies for managing animal pest populations through fertility control. Initially focused on agricultural applications, the company shifted its focus to urban rodent control.
Core Business Areas
- Pest Management: SenesTech develops and markets products for managing rodent populations, primarily focusing on fertility control as an alternative to lethal methods.
Leadership and Structure
The leadership team includes Robert Fry (CEO), and Lisa Nygren (CFO). The company has a board of directors overseeing its operations and strategy.
Top Products and Market Share
Key Offerings
- ContraPest: ContraPest is SenesTech's flagship product, a liquid rodenticide that induces infertility in both male and female rats. It targets the reproductive capabilities of rodents, aiming to reduce populations. Market share data is not publicly available in exact figures. Competitors include traditional rodenticides from companies like Bayer (BAYRY) and Syngenta (SYT).
Market Dynamics
Industry Overview
The pest control industry is a multi-billion dollar market, driven by concerns over public health, property damage, and food safety. Increasing urbanization and climate change are contributing to rodent populations. There is also a growing demand for more humane and environmentally friendly pest control solutions.
Positioning
SenesTech positions itself as an innovator in fertility control for pest management, offering a unique alternative to traditional poisons. It appeals to environmentally conscious customers and those seeking a long-term solution to rodent infestations.
Total Addressable Market (TAM)
The estimated global pest control market is substantial, reaching tens of billions of dollars. SenesTech aims to capture a portion of this market by offering a differentiated product focused on urban rodent control and fertility management.
Upturn SWOT Analysis
Strengths
- Unique product offering (fertility control)
- Environmentally friendly approach
- Potential for long-term population control
- Intellectual property protection
Weaknesses
- Limited financial resources
- Smaller market share compared to established players
- Slower initial adoption rate due to novel approach
- Dependence on a single product
Opportunities
- Growing demand for humane pest control
- Expansion into new markets and applications
- Partnerships with municipalities and pest control companies
- Increasing regulatory pressure on traditional rodenticides
Threats
- Competition from established pest control companies
- Development of alternative pest control technologies
- Regulatory hurdles and approval processes
- Resistance to fertility control methods among some users
Competitors and Market Share
Key Competitors
- BAYRY
- SYT
Competitive Landscape
SenesTech has an advantage in offering a non-lethal solution, but it faces challenges in competing with the established distribution networks and brand recognition of larger pest control companies.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been uneven, with periods of rapid expansion followed by periods of slower growth.
Future Projections: Future growth projections depend on successful product adoption, expansion into new markets, and securing strategic partnerships.
Recent Initiatives: Recent initiatives have included expanding sales and marketing efforts, forging collaborations with pest control service providers, and pursuing regulatory approvals in new regions.
Summary
SenesTech is a small, innovative company with a unique fertility control product for rodent management. While the company's environmentally friendly approach is a strength, its limited resources and smaller market share pose challenges. Future success depends on expanding market reach and securing strategic partnerships. The market is huge but it needs to expand fast to compete with bigger companies.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company reports
- Industry analysis reports
- Press releases
- Third-party market research
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is based on estimates and may not be precise. Investment decisions should be based on thorough research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About SenesTech Inc
Exchange NASDAQ | Headquaters Phoenix, AZ, United States | ||
IPO Launch date 2016-12-08 | CEO, President & Director Mr. Joel L. Fruendt | ||
Sector Basic Materials | Industry Specialty Chemicals | Full time employees 23 | Website https://www.senestech.com |
Full time employees 23 | Website https://www.senestech.com | ||
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption, as well as Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice after one to two breeding cycles following consumption. The company also provides teleconsulting and technical advisory services. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.